Sev­er­al months in­to a mul­ti­year quest to “rig­or­ous­ly pri­or­i­tize” its pipeline, Take­da is cut­ting a hand­ful of pro­grams. The com­pa­ny re­vealed the changes on Thurs­day … ...

Alumis (ALMS) stock gains as Oppenheimer initiates coverage with an Outperform recommendation, citing a valuation disconnect. Read more here.

Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...

TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

Gross domestic product increased at a 2.3 per cent annualized rate last quarter after accelerating at a 3.1 per cent pace in ...

Suffolk, one of the largest and most innovative real estate and construction enterprises in the country, recently celebrated topping off 585 Kendall. Designed by CBT Architects, 585 Kendall is a mixed ...

In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...

Guidance for 2025 from UPS falls short of estimates. Altria Group, the maker of tobacco products, posts quarterly earnings in line with expectations. Fourth-quarter per-share earnings of 80 cents top ...

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. | Takeda has named Julie Kim ...

Christophe Weber will step down as CEO of Takeda next year, the company announced, following a dropoff in its share price ...

A summary of current health news including Cigna's profit decline, Robert F. Kennedy Jr.'s Senate hearings, an Ebola outbreak ...